CAMKK2 inhibitor

CAMKK2 inhibitors are a class of small molecule compounds designed to inhibit calcium/calmodulin-dependent protein kinase kinase 2 (CAMKK2), a serine/threonine kinase that serves as an upstream activator of several key signaling pathways, including AMPK, CAMK1, CAMK4, and AKT. CAMKK2 is frequently dysregulated in various diseases, particularly prostate cancer, where it is regulated by the androgen receptor and promotes cell growth and metabolic reprogramming. Beyond oncology, CAMKK2 inhibition is being investigated for metabolic disorders such as obesity, non-alcoholic fatty liver disease (NAFLD), and insulin resistance, as the kinase plays a role in regulating systemic insulin levels and glucose homeostasis. While research tool compounds like STO-609 have been widely used in preclinical studies, they often suffer from poor pharmacological properties. Current drug discovery efforts focus on developing more potent and selective ATP-competitive inhibitors and ligand-directed degraders (LDDs).

Other names

CAMKK2 inhibitorsCAMKK-2 inhibitorsCAMKK 2 inhibitorsCaMKK2 inhibitorCaMKK-2 inhibitorCaMKK 2 inhibitorCaMKKbeta inhibitorcalcium/calmodulin-dependent protein kinase kinase 2 inhibitor